SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-025630
Filing Date
2019-04-23
Accepted
2019-04-23 19:13:13
Documents
1
Period of Report
2018-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1515
  Complete submission text file 0001209191-19-025630.txt   2872
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Issuer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1333 S. SPECTRUM BLVD #100 CHANDLER AZ 85286
Business Address
Vanhove Geertrui (Reporting) CIK: 0001771994 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35902 | Film No.: 19762393